Cytyc outbids Ventana for Vision Systems
This article was originally published in Clinica
Cytyc is preparing to trump Ventana Medical Systems' US$346m offer for Vision Systems, the Australian cancer testing systems maker. One month after Ventana and Vision Systems agreed on a Aus$2.13 (US$1.61) a share acquisition (see Clinica No 1219, p 2), Cytyc has announced its intention to offer Aus$2.35 a share, or about US$374m in total. Both offers are cash.